Immunoassays • Snibe Diagnostic

Maglumi SARS-CoV-2 Neutralizing Antibody (CLIA)

Highlights:
Addressing the urgent need of assessing immunity during the COVID-19 pandemic

• An important tool of the COVID-19 vaccine efficacy assessment
• Evaluating immunity in individuals and community to provide immunity “certification” for returning to society
• Cost-effective and large-scale solution for neutralizing antibody test
• Highly sensitive and specific detection of neutralizing antibodies: 100 percent positive agreement to gold standard